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Epidemiological and Clinical Characteristics of Community-
Acquired Severe Sepsis and Septic Shock: A Prospective 
Observational Study in 12 University Hospitals in Korea
A prospective multicenter observational study was performed to investigate the 
epidemiology and outcomes of community-acquired severe sepsis and septic shock. 
Subjects included 1,192 adult patients admitted to the 22 participating intensive care 
units (ICUs) of 12 university hospitals in the Korean Sepsis Registry System from April, 
2005 through February, 2009. Male accounted for 656 (55%) patients. Mean age 
was 65.0 ± 14.2 yr. Septic shock developed in 740 (62.1%) patients. Bacteremia was 
present in 422 (35.4%) patients. The 28-day and in-hospital mortality rates were 
23.0% and 28.0%, respectively. Men were more likely to have comorbid illnesses and 
acute organ dysfunctions, and had higher mortality and clinical severity compared to 
women. While respiratory sources of sepsis were common in men, urinary sources 
were predominant in women. In the multivariate logistic regression analysis, cancer 
(odds ratio 1.89; 95% confidence interval 1.13-3.17), urinary tract infection (0.25; 
0.13-0.46), APACHE II score (1.05; 1.02-1.09), SOFA score on day 1 (1.13; 1.06-
1.21) and metabolic dysfunction (2.24, 1.45-3.45) were independent clinical factors 
for gender-related in-hospital mortality. This study provided epidemiological and 
clinical characteristics of community-acquired severe sepsis and septic shock in ICUs in 
Korea, and demonstrated the impact of clinical factors on gender difference in 
mortality.
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INTRODUCTION
Severe sepsis is a syndrome triggered by systemic inflammation, 
coagulopathy, and acute organ dysfunction in response to in-
fection (1). It is an important reason for admission to intensive 
care units (ICUs) and the leading cause of death in non-coro-
nary ICUs, resulting in an economic burden in intensive care 
(2). Despite advances in knowledge of pathogenesis, diagnosis, 
therapeutic care, and supportive care, the incidence and mor-
tality of severe sepsis and septic shock has increased over the 
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past few decades. The proportion of patients with suggestive 
severe sepsis increased from 19.1% in the first 11 yr of the study 
period between 1979 and 2000 to 30.2% in later years in the Unit-
ed States (2, 3). Angus et al. (4) estimated that 751,000 cases of 
severe sepsis occur annually in the USA, with a mortality rate of 
28.6%, leading to an average cost per case of US$22,100. 
 Previous epidemiological studies have reported that men have 
higher incidence and mortality compared with women (2, 4, 5), 
however, a limited number of factors have been identified that 
could explain the gender disparity. Certain sources of infection 
and organisms are more likely to cause sepsis or the develop-
ment of acute organ dysfunction (1, 5-7), and chronic comor-
bid medical conditions strongly influence outcomes of patients 
with sepsis (8).  
 There is a limited but growing amount of information concern-
ing the epidemiology of sepsis in a variety of countries around 
the world. Accurate national data on sepsis may be useful for a 
variety of reasons, including the establishment of health care 
policy and the allocation of healthcare resources (2). However, 
there is a paucity of data regarding epidemiology and outcomes 
of patients managed in ICUs for community-acquired severe 
sepsis and septic shock in Korea (9, 10). 
 The purpose of the study was to investigate epidemiology and 
outcomes of community-acquired severe sepsis and septic shock 
in ICUs in Korea, focusing on the impact of gender on the clini-
cal characteristics and outcomes. 
MATERIALS AND METHODS
Study design and settings
This is a prospective, multi-center, observational study to inves-
tigate the epidemiology and outcomes of patients with commu-
nity-acquired severe sepsis and septic shock who were enrolled 
from April, 2005 to February, 2009, through the Korean Sepsis 
Registry System (KSRS) endorsed by the Korean Society of In-
fectious Diseases. The subjects included adult patients (≥ 18 yr) 
who had severe sepsis or septic shock within 24 hr of entry to the 
emergency room or ICU, and excluded those with nosocomial 
infection as defined elsewhere (11). Patients with health care-
associated risk factors who developed severe sepsis or septic 
shock in the community were also included (12). Only first ICU 
admission from one patient was included and followed-up un-
til death or hospital discharge.
 Eight university hospitals (8 medical and 6 surgical ICUs) lo-
cated in Seoul were invited and voluntary for participation from 
the beginning of the study, followed by both medical and surgi-
cal ICUs of other 4 university hospitals one year later (Seoul [n =  
1], Gyeonggi [n = 2] and Gangwon [n = 1] provinces). The study 
protocol for enrollment and assessment of the patients were 
developed by the steering committee of the KSRS that consisted 
of representative infectious disease specialists. 
Definitions
Infection was defined as microbiologically documented, and 
classified according to the standard definitions of the Centers 
for Disease Control and Prevention (11) and/or clinically sus-
pected infection, plus the administration of antibiotics. Primary 
infection site was assessed by the infectious diseases specialist 
in each participating hospital, based on the responsible micro-
organisms isolated and the organ(s) affected. Definitive micro-
organisms were defined by organisms isolated from a normally 
sterile site by routine culture, including blood, peritoneal or pleu-
ral fluid, cerebrospinal fluid, surgical specimen, or synovial flu-
id, or a bacterial pathogen isolated from cultures of respiratory 
specimens or a urine specimen with bacterial growth of ≥ 1 ×  
103 colony-forming units/mL. Sepsis and sepsis-related condi-
tions were diagnosed in accordance with the criteria proposed 
by ACCP/SCCM (American College of Chest Physician/Society 
of Critical Care Medicine) (1). Definition of severe sepsis was 
the presence of sepsis plus at least one organ or system dysfunc-
tion. The criteria for acute organ or system dysfunction were 
modified from previous criteria (13): cardiovascular dysfunc-
tion (systolic blood pressure ≤ 90 mmHg or mean arterial pres-
sure ≤ 70 mmHg that responds to administration of intravenous 
fluid), renal dysfunction (urine output < 0.5 mL/kg/hr for 1 hr 
despite adequate fluid resuscitation or serum creatinine ≥ 177 
μM not attributable to chronic kidney failure), respiratory dys-
function (ratio of partial arterial oxygen tension to inspired frac-
tional oxygen ≤ 200), hematologic dysfunction (platelet < 100 ×  
103/µL or platelet decreased to < 50% in the 2 days preceding 
admission or INR (International Normalized Ratio) > 1.5 in the 
absence of systemic anticoagulant agents), hepatic dysfunction 
(bilirubin > 43 μM or alanine transaminase > 50 IU/L), central 
nervous system dysfunction (documentation of deterioration 
in mental status within 24 hr before admission), gastrointesti-
nal dysfunction (active gastrointestinal tract bleeding requiring 
transfusions within 24 hr of onset of sepsis), metabolic dysfunc-
tion (arterial pH ≤ 7.30 or the base deficit ≥ 5.0 mM in associa-
tion with a plasma lactate > 2 times the upper limit of the nor-
mal value). Septic shock was defined as either systolic blood pres-
sure ≤ 90 mmHg or mean arterial pressure ≤ 70 mmHg for at 
least 1 hr after adequate fluid resuscitation or use of vasopres-
sors to maintain systolic blood pressure > 90 mmHg or mean 
arterial pressure > 70 mmHg. 
Data collection and management
Data from each patient were collected on standardized web-
based case report form by the physicians or research nurses in 
each hospital. They were provided detailed instructions explain-
ing the aim of the study, instructions for data collection, and def-
initions for variables by operating manual before starting data 
collection and throughout the study period. The coordinating 
center at the Korea University Anam Hospital supported data 
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registration at each center, and all data were checked to be with-
in acceptable ranges. 
 Data collection on admission included demographic data, 
presence of underlying comorbidity, Charlson’s index score (14). 
Acute Physiology and Chronic Health Evaluation (APACHE) II 
score (15), Sequential Organ Failure Assessment (SOFA) score 
(16), microbiology and clinical infections were collected. We 
recorded the admission date to ICU and the date of in hospital-
death or hospital discharge. Sepsis-related mortality was judged 
by investigators in the participating hospitals.
Statistical analyses
Descriptive analysis was performed. Differences of categorical 
variables were compared using the chi-square test or Fisher ex-
act test. Continuous variables were expressed as mean ± stan- 
dard deviation (SD), and Student’s two-tailed t test and two-way 
ANOVA were used for comparing means. To determine the ef-
fect of gender on 28-day and in-hospital mortality, multiple lo-
gistic regression analysis with forward variable selection meth-
od was done. The all variables significant in univariate analysis 
(P < 0.05) were included in the multivariate model. Odds ratio 
(OR) and 95% confidence interval (CI) were calculated accord-
ing to standard methods after adjusting for confounding factors. 
All tests were two-tailed and a P  value < 0.05 was considered 
significant. Data were analyzed using SPSS version 13.0 for Win-
dows (SPSS, Chicago, IL, USA). 
Ethics statement
The study protocol was approved by the institutional review 
board of the Korea University Anam Hospital (IRB No. ED 0513). 
Since this observational study required no deviation from rou-
tine medical practice, informed consent was waived by board.
RESULTS
Demographic and basal clinical characteristics 
During the study period, a total of 1,192 patients met the enroll-
ment criteria for the community-acquired severe sepsis or sep-
tic shock. The demographic and baseline clinical characteristics 
of patients by gender are shown in Table 1. Men accounted for 
55% (656/1,192), and had lower mean age than in women (63.9 ±  
14.0 yr vs 66.4 ± 14.8 yr; P = 0.003). The peak of age distribution 
was 60-69-yr-of-age. 
 Any type of comorbidity was present in 847 (71.1%) patients. 
Men had higher rates of central nervous system diseases, can-
cer, liver diseases and lung diseases. However, cardiovascular 
diseases and connective tissue diseases were higher in women. 
The severity of comorbidity as measured by Charlson’s index 
score was also greater in men.
 The most common primary site of infection was the respira-
tory system, followed by urinary tract, abdomen, skin and soft 
tissue and primary bloodstream. Men were more likely to have 
respiratory (39.2% vs 19.2%, P < 0.001), abdominal (26.8% vs 
20.9%, P = 0.017) and skin and soft tissue infections (11.0% vs 
4.7%, P < 0.001), compared to women. Women showed higher 
rates of urinary tract infections (11.4% vs 44.8%, P < 0.001). 
 Clinical infections with identification of pathogens were doc-
umented in 831 (69.7%) patients. Distribution of microorgan-
isms and sites of isolation were shown in Table 2. Gram nega-
tive bacteria were the predominant organisms of the isolates, 
accounting for 43.0% (n = 513), while gram positive bacteria ac-
counted for 20.4% (n = 243). Polymicrobial infections accounted 
for 3.6%, followed by fungi (0.7%) and anaerobes (0.6%). Esche-
richia coli (22.1%) was the most common isolate, followed by 
Klebsiella species (12.6%) and Staphylococcus aureus (8.4%). 
Bacteremia developed in 35.4% (422/1,192) of patients, with the 
frequency of E. coli (37.7%; 159/422), Klebsiella species (22.0%; 
93/422), and S. aureus (11.8%; 50/422). Based on clinical sam-
Table 1. Demographic and basal characteristics of the 1,192 patients with commu-
nity-acquired severe sepsis and septic shock
Variables All (%)
No.(%) of patients
 P  valueMales (%) 
(n = 656)
Females (%) 
(n = 536)
Age (mean ± SD, yr) 
  < 40
   40-49
   50-59
   60-69
   70-79
  ≥ 80
65.0 ± 14.2
  66 (5.5)
115 (9.6)
  197 (16.5)
  325 (27.3)
  304 (25.5)
  185 (15.5)
63.9 ± 14.0
32 (4.9)
  72 (11.0)
130 (19.8)
180 (27.4)
162 (24.7)
  80 (12.2)
66.4 ± 14.8
34 (6.3)
43 (8.0)
  67 (12.5)
145 (27.1)
142 (26.5)
105 (19.6)
0.003
Comorbid illness
   Cardiovascular 
   Central nervous system 
   Cancer
   Trauma
   Renal 
   Liver 
   Lung 
   Organ transplant
   Connective tissue 
   Metabolic 
   Hematological 
   HIV 
   Others*
   Any type of comorbidity
   Charlson score (mean± SD)
 
  448 (37.6)
  171 (14.3)
  175 (14.7)
  16 (1.3)
  49 (4.1)
  98 (8.2)
104 (8.7)
  18 (1.5)
  22 (1.8)
  335 (28.1)
  37 (3.1)
    6 (0.5)
  36 (3.0)
  847 (71.1)
1.3 ± 1.7
 
222 (33.8)
110 (16.8)
115 (17.5)
10 (1.5)
29 (4.4)
  73 (11.1)
  77 (11.7)
13 (2.0)
  4 (0.6)
175 (26.7)
23 (3.5)
  3 (0.5)
22 (3.4)
485 (73.9)
1.5 ± 1.8
 
226 (42.2)
  61 (11.4)
  60 (11.2)
  6 (1.1)
20 (3.7)
25 (4.7)
27 (5.0)
  5 (0.9)
18 (3.4)
160 (29.9)
14 (2.6)
  3 (0.5)
  8 (1.5)
363 (67.7)
1.1 ± 1.4
  
0.03
0.01
0.02
0.62
0.66
< 0.001
< 0.001
0.159
0.001
0.244
0.406
1.000
0.043
0.021
< 0.001
Source of primary infection
   Abdomen
   Bone and joint
   Cardiovascular system
   Central nervous system
   Head and neck
   Bloodstream
   Respiratory system
   Reproductive tract
   Skin and soft tissue
   Systemic infection
   Urinary tract
   Unknown
 
  288 (24.2)
  11 (0.9)
  18 (1.5)
  18 (1.5)
    6 (0.5)
  52 (4.4)
  360 (30.2)
    4 (0.3)
  97 (8.1)
  21 (1.9)
  315 (26.4)
    2 (0.2)
 
176 (26.8)
  6 (0.9)
12 (1.8)
12 (1.8)
  3 (0.5)
31 (4.7)
257 (39.2)
0
  72 (11.0)
11 (1.7)
  75 (11.4)
  1 (0.2)
 
112 (20.9)
  5 (0.9)
  6 (1.1)
  6 (1.1)
  3 (0.5)
21 (3.9)
103 (19.2)
  4 (0.7)
25 (4.7)
10 (1.9)
240 (44.8)
  1 (0.2)
 
0.017
1.00
0.350
0.350
1.00
0.569
< 0.001
< 0.001
0.828
< 0.001
1.000
*ulcer diseases, hemiplegia, etc. SD, standard deviation.
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ples for the bacterial isolates, Streptococcus pneumoniae, S. au-
reus and Klebsiella species were more frequently isolated from 
respiratory samples. E. coli and Klebsiella species were the most 
frequent isolates from abdominal aspirates. Gram positive bac-
teria were more common in male patients than in female pa-
tients (25.3% vs 14.4%, P < 0.001), whereas gram negative organ-
isms were more common in female patients (36.6% vs 50.9%, 
P < 0.001). 
Clinical severity and outcomes
Clinical severity and outcomes of the 1,192 patients analyzed 
are shown in Table 3. The mean APACHE II score of patients on 
ICU admission was 18.8 ± 7.3. The mean number of organ dys-
functions within 24 hr after admission was 2.6 ± 1.6. The hema-
tologic dysfunction was the most frequent, acute organ dysfunc-
tion, followed by hepatic, renal, respiratory, metabolic, cardio-
vascular, and gastrointestinal dysfunction. The mean SOFA score 
was 7.5 points on day 1, and decreased to 5.0 points on day 5. 
There were significant differences between men and women in 
the mean APACHE II score, the mean SOFA score, and in occur-
rence of acute organ dysfunction. Men were more likely to have 
renal, respiratory, hepatic, and metabolic organ dysfunction, 
compared to women (P < 0.05). 
 Septic shock was present in 62.1% (740/1,192) of patients. There 
was no difference in the presence of septic shock between men 
and women. Development of septic shock was significantly as-
sociated with source of primary infection; abdomen (OR, 1.31; 
95% CI, 0.96-1.77, P = 0.088), bloodstream (2.24; 1.12-4.49, P =  
0.023), respiratory system (0.64; 0.48-0.84, P = 0.001). 
 The overall 28-day, in-hospital, and sepsis-related mortality 
rates were 23.0% (n = 274), 28.0% (n = 334), and 23.6% (n = 281), 
respectively (Table 3). The patients with septic shock had signif-
icantly higher mortality rates compared to those without septic 
shock: the 28-day mortality rate (26.1% vs 17.9%, P = 0.001), in-
hospital mortality rate (30.8% vs 23.5%, P = 0.006), and sepsis-
related mortality rate (27.2% vs 17.7%, P < 0.001). There are also 
significant differences between men and women in 28-day, in-
hospital, and sepsis-related mortality rates. Men had significant-
ly higher mortality in all of the age groups compared to women 
(Fig. 1). 
 The mean length of hospital stay for survivors and non-survi-
vors was 26.5 ± 34.5 days and 21.1 ± 45.7 days, respectively. How-
ever, there was no significant gender difference in length of hos-
pital stay for survivors or non-survivors. 
Risk factors related to mortality difference by gender
Multiple logistic regression analysis was performed to identify 
the risk factors which could explain the differences of the 28-day 
mortality and in-hospital mortality between men and women. 
Independent variables that were significantly different between 
men and women in univariate analysis were included in the 
models. The significant variables selected in the final model of 
Table 2. Frequencies of microorganisms isolated and the related clinical specimens in the 1,192 patients with community-acquired severe sepsis and septic shock
Microorganisms
No. (%) of samples
Blood  
(n = 643)
Urine  
(n = 154)
 Respiratory  
 (n = 244)
Abdominal  
aspiration (n = 50)
   Wound  
   (n = 49)
   Others  
   (n = 52)
Gram positive
   Staphylococcus aureus
   Coagulase-negative staphylococci
   Streptococcus pneumoniae
   Streptococcus species
   Enterococcus species
   Other gram positives*
 
50 (7.8)
5 (0.8)
13 (2.0)
29 (4.5)
8 (1.2)
1 (0.2)
 
2 (1.3)
0
0
3 (1.9)
10 (6.5)
0
 
31 (12.7)
1 (0.4)
37 (15.2)
6 (2.5)
0
0
 
0
0
0
2 (4.0)
3 (6.0)
0
 
13 (26.5)
1 (2.0)
0
11 (22.4)
3 (6.1)
0
 
4 (7.7)
1 (1.9)
4 (7.7)
3 (5.8)
2 (3.8)
0
Gram negative
   Escherichia coli
   Klebsiella species
   Pseudomonas species
   Enterobacter species
   Vibrio vulnificus
   Other Enterobacteriaceae †
   Other gram negatives‡
 
153 (23.8)
88 (13.7)
11 (1.7)
9 (1.4)
6 (0.9)
11 (1.7)
9 (1.4)
 
78 (50.6)
14 (9.1)
5 (3.2)
2 (1.3)
0
5 (3.2)
1 (0.6)
 
4 (1.6)
28 (11.5)
12 (4.9)
4 (1.6)
0
4 (1.6)
6 (2.5)
 
17 (34.0)
15 (30.0)
3 (6.0)
1 (2.0)
0
0
0
 
4 (8.2)
1 (2.0)
3 (6.1)
1 (2.0)
0
3 (6.1)
0
 
7 (13.5)
4 (7.7)
0
0
0
1 (1.9)
3 (5.8)
Polymicrobial 23 (3.6) 6 (3.9) 6 (2.5) 3 (6.0) 3 (6.1) 2 (3.8)
Anaerobe 7 (1.1) 0 0 0 0 0
Fungus 6 (0.9) 1 (0.6) 1 (0.4) 0 0 0
Virus 3 (0.5) 0 0 0 0 1 (1.9)
Mycobacterium 0 0 4 (1.6) 0 0 0
Other microorganisms§ 7 (1.1) 0 1 (0.4) 0 0 1 (1.9)
Unproven 204 (31.7) 27 (17.5) 99 (40.6) 6 (12.0) 6 (12.2) 19 (36.5)
*Micrococcus species; †Proteus species, Morganella morganii, Serratia marcescens, Citrobacter species; ‡Hemophilus influenzae, Acinetobacter lwoffii, Raoultella ornithinolytica, 
Actinomyces species, Hafnia alvei, Legionella pneumophila, Aeromonas hydrophila, Salmonella species, Pantoea species, Vibrio cholera; §Orientia tsutsugamushi, Pneumocystis 
jiroveci, Plasmodium falciparum.
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the 28-day mortality were urinary tract infection (OR, 0.33; 95% 
CI, 0.17-0.59), APACHE II score (1.06; 1.02-1.09), SOFA score on 
day 1 (1.11; 1.04-1.18) and metabolic dysfunction (2.09; 1.36-
3.22). In the model of in-hospital mortality, cancer (1.89; 1.13-
3.17), urinary tract infection (0.25; 0.13-0.46), APACHE II score 
(1.05; 1.02-1.09), SOFA score on day 1 (1.13; 1.06-1.21) and met-
abolic dysfunction (2.24, 1.45-3.45) were significant variables 
selected (Table 4). However, both age and gender were not sig-
nificant variables. 
DISCUSSION
This prospective, multi-center, observational study has primar-
ily investigated the epidemiological characteristics and clinical 
outcomes of patients with community-acquired severe sepsis 
and septic shock in the 22 ICUs of 12 university hospitals in Ko-
rea, although several analyses have been planned based on the 
database of the KSRS, including the recently published substudy 
on the prognostic factors for community-acquired bacteremic 
severe sepsis (10). The current study has disclosed the overall 
mortality, the most common site of primary infection, the pre-
dominant bacterial pathogens isolated from clinical specimens, 
clinical severity and occurrence of acute organ dysfunctions 
among adult patients with community-acquired severe sepsis. 
In addition, this study has shown gender-related differences in 
clinical characteristics and determined clinical factors related 
to gender-related mortality. 
 In this study, in-hospital mortality rate of 28.0% was within the 
ranges of the expected mortality according to a mean APACHE 
II score of 18.8 (i.e. 22%) and initial mean SOFA score of 7.5 (i.e. 
33%) (15, 16), and was comparable to that of 28.6% from a review 
of hospital discharge data from seven U.S. states during 1995 (4) 
Table 4. Multivariate logistic regression analysis of risk factors associated with gender difference in mortality
Variables 
28-day mortality In-hospital mortality
OR (95% CI) P  value OR (95% CI) P  value
Cancer - - 1.891 (1.128-3.172) 0.016
Urinary tract infection 0.322 (0.174-0.594) < 0.001 0.249 (0.133-0.464) < 0.001
APACHE II score 1.057 (1.022-1.092) 0.001 1.054 (1.020-1.090) 0.002
SOFA score on day 1 1.105 (1.037-1.178) 0.002 1.133 (1.063-1.209) < 0.001
Metabolic dysfunction 2.091 (1.357-3.222) < 0.001 2.240 (1.453-3.452) < 0.001
*The variables in the final model were selected by forward variable selection method. Age, sex, comorbid illness (cardiovascular, central nervous system, cancer, liver, lung, con-
nective tissue disease, Charlson’s score), sites of primary infection (abdomen, respiratory system, skin and soft tissue, urinary track), organ dysfunctions (renal, respiratory, he-
patic, metabolic) and prognostic factors (APACHE II score and initial SOFA score) were included in initial model. 
M
or
ta
lit
y 
(%
)
Age groups (yr)
 < 40 40-49 50-59 60-69 70-79 > 80
40
35
30
25
20
15
10
5
0
28-day mortality (male)
In-hospital mortality (male)
28-day mortality (female)
In-hospital mortality (female)
Fig. 1. Gender difference of 28-day and in-hospital mortalities by sex. 
Table 3. Clinical severity and outcome of the 1,192 patients with community-acquired 
severe sepsis and septic shock
Variables All (%)
No. (%) of patients
  P  valueMales (%) 
(n = 656)
Females (%) 
(n = 536)
APACHE II score* 
   (mean ± SD)
 18.8 ± 7.3  19.6 ± 7.3  17.8 ± 7.2 < 0.001
Organ dysfunction*
   Number (mean± SD)
   Cardiovascular
   Renal
   Respiratory
   Hematologic
   Hepatic
   Central nervous system
   Gastrointestinal
   Metabolic
   Septic shock
 
 2.6 ± 1.6*
149 (12.5)
472 (39.6)
399 (33.5)
742 (62.2)
475 (39.8)
437 (36.7)
30 (2.5)
349 (29.3)
740 (62.1)
 
2.8 ± 1.6
  82 (12.5)
289 (44.1)
248 (37.8)
415 (63.3)
291 (44.4)
258 (39.3)
15 (2.3)
212 (32.3)
400 (61.0)
 
2.3 ± 1.5
  67 (12.5)
183 (34.1)
151 (28.2)
327 (27.4)
184 (34.3)
179 (33.4)
15 (2.8)
137 (25.6)
340 (63.4)
 
< 0.001
1.00
0.001
0.001
0.435
< 0.001
0.350
0.583
0.013
0.401
SOFA score (mean ± SD)
   Admission day 1
 
   Admission day 2
 
   Admission day 3
 
   Admission day 4
 
   Admission day 5
 
 
7.5 ± 3.9 
(968)†
6.6 ± 4.4 
(1144)†
6.0 ± 4.5 
(1105)†
5.4 ± 4.6 
(1081)†
5.0 ± 4.6 
(1049)†
 
8.1 ± 4.0
 
7.3 ± 4.5
 
6.7 ± 4.7
 
6.1 ± 4.8
 
 5.79 ± 4.7
 
 
6.8 ± 3.6
 
5.8 ± 4.0
 
5.3 ± 4.3
 
4.6 ± 4.3
 
4.2 ± 4.4
 
 
< 0.001
 
< 0.001
 
< 0.001
 
< 0.001
 
< 0.001
 
Mortality
   28-day 
   In-hospital 
   Sepsis-related 
 
274 (23.0)
334 (28.0)
281 (23.6)
 
177 (27.0)
216 (32.9)
184 (28.3)
 
  97 (18.1)
118 (22.0)
  97 (18.1)
 
< 0.001
< 0.001
< 0.001
Length of hospital stay 
   (mean ± SD, days)
   Survivors
   Non-survivors
 
 
26.5 ± 34.5
21.1 ± 45.7
 
 
30.4 ± 37.1
21.6 ± 44.1
 
 
22.4 ± 31.0
20.1 ± 48.7
 
 
0.202‡
*within 24 hr of admission; †number of patient evaluated; ‡by two-way ANOVA. SD, 
standard deviation; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, 
Sepsis-related Organ Failure Assessment.
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and that of 27.6% from sepsis and septic shock patients admit-
ted through emergency departments in Australia and New Zea-
land (17). However, the current mortality rate is lower than those 
reported in other studies (18-20). The reasons for the differenc-
es in mortality rates may relate to differences in the definition 
used for diagnosis of severe sepsis and septic shock, communi-
ty-acquired or hospital-acquired infection, severity of sepsis, 
and healthcare system issues. 
 In this study, we observed gender differences in mean age, 
chronic comorbidity, source of primary infection, occurrence 
of acute organ dysfunctions and mortality among the ICU pa-
tients with severe sepsis and septic shock. Men had significant-
ly higher 28-day and in-hospital mortality rates in all age groups 
compared to women. However, both gender and age were not 
related to the higher mortality in men in our final multiple lo-
gistic regression models (Table 4). We also identified that clini-
cal severity (APACHE II score and initial SOFA score), comor-
bidity (cancer), source of infection (urinary tract infection), and 
metabolic organ dysfunction were significantly independent 
risk factors for the gender-related mortality in our study popu-
lation. Certain comorbid conditions such as diabetes mellitus, 
chronic liver diseases, HIV, and cancer have been suggested to 
increase the risk of developing sepsis (4, 21, 22). Sex disparity in 
the source of infection has also been examined in previous stud-
ies (23, 24). Urinary tract infection rate was lower in men than 
women, which can contribute to lower mortality rate in women 
in our study. 
 There has been an inconsistency regarding gender-mortality 
relationships in clinical sepsis studies. Women have better prog-
nosis in some studies (25, 26), whereas other studies found no 
gender differences (2, 4). In contrast, in a large cohort study of 
ICU patients published recently, women with severe sepsis or 
septic shock have a higher risk of in-hospital mortality than men 
after multivariable adjustment. Although the study identified 
significant gender differences in some care delivery (deep ve-
nous thrombosis prophylaxis, invasive mechanical ventilation, 
hemodialysis catheter etc.) and in numerous other observed 
covariates (age, site of infection, functional status, and comor-
bid conditions), these factors cannot explain the observed gen-
der difference (27). Considering these conflicting reports, the 
role of clinical severity, comorbidity and infection sites in gen-
der-related mortality of severe sepsis in our study provide a cat-
alyst for additional investigations. 
 In previous studies, infection with gram positive cocci (e.g., 
methicillin-resistant S. aureus) and the site of infection influ-
enced the occurrence of acute organ dysfunction and subse-
quent clinical outcomes (6, 7). In this study, we observed that 
septic shock was present in 62.1% of the patients, and develop-
ment of septic shock was significantly associated with source of 
primary infections such as abdomen, bloodstream and respira-
tory system. These findings might have clinical implications in 
management of septic shock after additional investigations.
 This study has some limitations. First, this study did not in-
clude a random sample of ICUs, potentially leading to selection 
bias. Second, there could be an inclusion bias since all the sep-
tic patients may not have been entered into our database due to 
the long study period and voluntary participation. Third, this 
study analyzed the risk factors related to the gender difference 
in mortality. Further study needs determination of the risk fac-
tors for mortality, including variables of clinical severity and ap-
propriateness of antimicrobial therapy. 
 In conclusion, to our knowledge, this study is the largest pro-
spective multi-center, observational study to date providing the 
clinical characteristics and gender disparities in patients with 
community-acquired severe sepsis and septic shock in ICUs in 
Korea. In particular, this study concluded that men might be re-
lated with higher clinical severity and mortality, however, gender 
itself is not a significant risk factor for mortality of severe sepsis 
and septic shock. 
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